An employee of German biopharmaceutical company CureVac, demonstrates research on a vaccine for the coronavirus (COVID-19) disease at a laboratory in Tuebingen, Germany, March 12, 2020. Andreas Gebert | REUTERS CureVac plans to continue work on its Covid-19 vaccine despite disappointing clinical trial results that showed the shot is just 48% effective. The German biotech… Read More »
Data from HIV Prevention England and the Terrence Higgins Trust show much lower levels of knowledge about HIV pre-exposure prophylaxis (PrEP) in people of Black African origin living in England than there is among gay and bisexual men, despite continuing high levels of risk behaviour and a much higher prevalence of HIV than people from… Read More »
A Harvard immunologist said current vaccines appear to be effective enough to end the pandemic, despite growing concerns that more infectious COVID-19 variants would severely blunt the effectiveness of the preventative treatments and set the nation back in its fight against the disease. Galit Alter, professor of medicine at Harvard Medical School and the Ragon… Read More »
Sydney’s shopping precincts have been swarmed by bargain hunters looking for Boxing Day deals, just hours after the premier praised the community for staying away. Some stores were nearly empty on Boxing Day morning, as customers heeded warnings to keep out of the CBD while NSW battles to contain its latest coronavirus outbreak. However, by… Read More »